IP Library Assignment 045755/0844
Patent Assignment
Reel/Frame 045755/0844

Change of Name

Recorded: 2018-03-28 Pages: 6
Assignor
MODERNA THERAPEUTICS, INC.
Executed: 2016-08-08
Assignee
MODERNATX, INC.
200 TECHNOLOGY SQUARE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties (50)
Modified Nucleic Acid Molecules and Uses Thereof
Application: 15/240,656 →
Publication: US US20160354493A1
Alternative Nucleic Acid Molecules and Uses Thereof
Application: 15/319,840 →
Publication: US US20170136131A1
Lipid Nanoparticle Compositions
Application: 15/545,392 →
Publication: US US20180000953A1
Alternative Nucleic Acid Molecules Containing Reduced Uracil Content and Uses Thereof
Application: 15/656,740 →
Publication: US US20180009866A1
Lipid Nanoparticle Compositions
Application: 15/545,376 →
Publication: US US20180085474A1
Polynucleotides Containing a Stabilizing Tail Region
Application: 15/760,686 →
Publication: US US20180256750A1
Polynucleotides Containing a Morpholino Linker
Application: 62/279,486 →
Polynucleotides Containing a Morpholino Linker
Application: 15/760,667 →
Publication: US US20190078087A1
Circular Polynucleotides
Application: 15/326,059 →
Publication: US US20170204422A1
Chimeric Polynucleotides
Application: 15/326,103 →
Publication: US US20170204152A1
Polynucleotide Formulations for Use in the Treatment of Renal Diseases
Application: 15/760,659 →
Publication: US US20190054112A1
Tolerogenic Compositions and Methods
Application: 15/508,221 →
Publication: US US20170348415A1
Multimeric Polynucleotides and Uses Thereof
Application: 62/620,170 →
Systems with Fluid Path Control and Regulation
Application: 62/546,815 →
Delivery and Formulation of Engineered Nucleic Acids
Application: 15/927,730 →
Publication: US US20190060458A1
Polyribonucleotides Containing Reduced Uracil Content and Uses Thereof
Application: 62/471,760 →
Modified Polynucleotides for the Production of Membrane Proteins
Application: 15/418,270 →
Modified Polynucleotides for the Production of Proteins
Application: 15/789,138 →
Publication: US US20190240351A1
Modified Polynucleotides for the Production of Proteins Associated with Human Disease
Application: 15/440,523 →
Publication: US US20180086807A1
Modified Polynucleotides for the Production of Biologics and Proteins Associated with Human Disease
Application: 15/790,246 →
Publication: US US20180311381A1
Modified Polynucleotides for the Production of Cytoplasmic and Cytoskeletal Proteins
Application: 15/425,645 →
Publication: US US20170368200A1
Modified Polynucleotides for the Production of Nuclear Proteins
Application: 15/662,090 →
Publication: US US20180170990A1
Modified Polynucleotides for the Production of Cosmetic Proteins and Peptides
Application: 15/845,911 →
Publication: US US20180360995A1
Modified Polynucleotides for the Production of Oncology-Related Proteins and Peptides
Application: 15/425,813 →
Publication: US US20180002393A1
In Vivo Production of Proteins
Application: 15/403,517 →
Publication: US US20170348436A1
Modified Nucleosides, Nucleotides, and Nucleic Acids, and Uses Thereof
Patent: 9,428,535 →
Application: 13/644,072 →
Publication: US US20130115272A1
Modified Polynucleotides for the Production of G-Csf
Patent: 8,680,069 →
Application: 13/897,367 →
Publication: US US20130253043A1
Formulation and Delivery of Plga Microspheres
Patent: 9,271,996 →
Application: 13/897,371 →
Publication: US US20130244278A1
Formulation and Delivery of Plga Microspheres
Patent: 9,295,689 →
Application: 13/897,375 →
Publication: US US20130252281A1
Split Dose Administration
Patent: 9,186,372 →
Application: 13/898,588 →
Publication: US US20130237594A1
Method for Producing a Protein of Interest in a Primate
Patent: 8,664,194 →
Application: 13/898,758 →
Publication: US US20130245104A1
Dlin-KC2-Dma Lipid Nanoparticle Delivery of Modified Polynucleotides
Patent: 8,754,062 →
Application: 13/898,870 →
Publication: US US20130245105A1
Modified Polynucleotides Encoding Hepatitis a Virus Cellular Receptor 2
Patent: 9,675,668 →
Application: 14/105,208 →
Publication: US US20140105966A1
Modified Polynucleotides for the Production of Proteins Associated with Blood and Lymphatic Disorders
Patent: 9,220,755 →
Application: 14/105,224 →
Publication: US US20140147432A1
Modified Polynucleotides for Treating Protein Deficiency
Patent: 9,061,059 →
Application: 14/171,226 →
Publication: US US20140249208A1
Modified Polynucleotides for Treating Galactosylceramidase Protein Deficiency
Patent: 9,089,604 →
Application: 14/171,249 →
Publication: US US20140221465A1
Modified Polynucleotides for the Production of Biologics and Proteins Associated with Human Disease
Patent: 8,999,380 →
Application: 13/791,922 →
Publication: US US20130259924A1
Modified Polynucleotides Encoding Aquaporin-5
Patent: 9,220,792 →
Application: 14/103,188 →
Publication: US US20140105964A1
Modified Polynucleotides Encoding Basic Helix-Loop-Helix Family, Member E41
Patent: 9,107,886 →
Application: 14/104,531 →
Publication: US US20140199371A1
Modified Polynucleotides Encoding CITED4
Patent: 9,114,113 →
Application: 14/104,556 →
Publication: US US20140186432A1
Modified Polynucleotides Encoding Copper Metabolism (MURR1) Domain Containing 1
Patent: 9,095,552 →
Application: 14/104,568 →
Publication: US US20140105965A1
Modified Polynucleotides for the Production of Proteins Associated with Blood and Lymphatic Disorders
Patent: 9,233,141 →
Application: 14/104,591 →
Publication: US US20140200262A1
Modified Polynucleotides for the Production of Secreted Proteins
Patent: 9,192,651 →
Application: 13/791,921 →
Publication: US US20130259923A1
Modified Polynucleotides Encoding Aryl Hydrocarbon Receptor Nuclear Translocator
Patent: 9,050,297 →
Application: 14/106,957 →
Publication: US US20140161873A1
Modified Polynucleotides for the Production of Nuclear Proteins
Patent: 9,283,287 →
Application: 14/694,357 →
Publication: US US20150246139A1
Modified Polynucleotides Encoding Apoptosis Inducing Factor 1
Patent: 9,301,993 →
Application: 14/106,988 →
Publication: US US20140107189A1
Modified Polynucleotides Encoding Granulysin
Patent: 9,216,205 →
Application: 14/107,053 →
Publication: US US20140113960A1
Modified Polynucleotides Encoding Septin-4
Patent: 9,149,506 →
Application: 14/107,079 →
Publication: US US20140141067A1
Modified Polynucleotides Encoding Siah E3 Ubiquitin Protein Ligase 1
Patent: 9,255,129 →
Application: 14/107,105 →
Publication: US US20140141068A1
Polyribonucleotides Containing Reduced Uracil Content and Uses Thereof
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 2, 2016
From: BUTORA, GABOR; MIRACCO, EDWARD JOHN; NELSON, JENNIFER; STANTON, MATTHEW
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 037646/0518 →
Assignment of Assignor's Interest Aug 8, 2016
From: FRALEY, ANDREW W.
To: MODERNA THERAPEUTICS, INC
Reel/Frame 039362/0462 →
Assignment of Assignor's Interest Feb 8, 2017
From: RHODEN SMITH, AMY
To: MODERNATX, INC.
Reel/Frame 041205/0668 →
Assignment of Assignor's Interest Jun 30, 2017
From: HOGE, STEPHEN; BENENATO, KERRY; PRESNYAK, VLADIMIR; MCFADYEN, IAIN
To: MODERNATX, INC.
Reel/Frame 042876/0676 →
Assignment of Assignor's Interest Nov 29, 2017
From: HOGE, STEPHEN G.; ISSA, WILLIAM JOSEPH; MIRACCO, EDWARD JOHN; NELSON, JENNIFER
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 044248/0829 →
Assignment of Assignor's Interest Feb 27, 2018
From: ALMARSSON, ORN; LAWLOR, CIARAN PATRICK
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045055/0127 →
Assignment of Assignor's Interest Feb 28, 2018
From: HOGE, STEPHEN G.; HUANG, ERIC YI-CHUN; O'DEA, LOUIS SAINT LAURENCE
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045067/0357 →
Assignment of Assignor's Interest Mar 29, 2018
From: WEISS, RON
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045385/0848 →
Assignment of Assignor's Interest Mar 29, 2018
From: BANCEL, STEPHANE; CHAKRABORTY, TIRTHA; DE FOUGEROLLES, ANTONIN; ELBASHIR, SAYDA M.
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045766/0096 →
Assignment of Assignor's Interest Apr 18, 2018
From: ROY, ATANU
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045969/0456 →
Assignment of Assignor's Interest Apr 18, 2018
From: BANCEL, STEPHANE; CHAKRABORTY, TIRTHA; FOUGEROLLES, ANTONIN DE; ELBASHIR, SAYDA M.
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045573/0842 →
Assignment of Assignor's Interest Apr 18, 2018
From: DE FOUGEROLLES, ANTONIN
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045575/0137 →
Assignment of Assignor's Interest Apr 18, 2018
From: FRALEY, ANDREW W.
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045575/0444 →
Assignment of Assignor's Interest Apr 18, 2018
From: CONLEE, CHRISTOPHER R.
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045575/0537 →
Assignment of Assignor's Interest Apr 18, 2018
From: BUTORA, GABOR; STANTON, MATTHEW
To: MODERNATX, INC.
Reel/Frame 045575/0857 →
Assignment of Assignor's Interest Apr 19, 2018
From: ELBASHIR, SAYDA M.; JOHN, MATTHIAS; ROY, ATANU; WOOD, KRISTY M.
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045592/0463 →
Assignment of Assignor's Interest Apr 19, 2018
From: BANCEL, STEPHANE; CHAKRABORTY, TIRTHA; DE FOUGEROLLES, ANTONIN; WHORISKEY, SUSAN
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045592/0230 →
Assignment of Assignor's Interest Apr 19, 2018
From: BANCEL, STEPHANE; CHAKRABORTY, TIRTHA; DE FOUGEROLLES, ANTONIN; ELBASHIR, SAYDA M.
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045591/0099 →
Assignment of Assignor's Interest Apr 20, 2018
From: ALMARSSON, ÖRN
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045600/0961 →
Assignment of Assignor's Interest Apr 20, 2018
From: LAWLOR, CIARAN PATRICK
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045601/0070 →
Assignment of Assignor's Interest May 16, 2018
From: CONLEE, CHRISTOPHER R.
To: MODERNATX, INC.
Reel/Frame 045817/0896 →
Assignment of Assignor's Interest May 17, 2018
From: NELSON, JENNIFER; FRALEY, ANDREW W.; RHODEN-SMITH, AMY
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045835/0149 →
Assignment of Assignor's Interest May 17, 2018
From: NELSON, JENNIFER; FRALEY, ANDREW W.; RHODEN-SMITH, AMY
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045833/0884 →
Assignment of Assignor's Interest May 21, 2018
From: MIRACCO, EDWARD JOHN; NELSON, JENNIFER
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045859/0577 →
Assignment of Assignor's Interest May 21, 2018
From: FRALEY, ANDREW W.
To: MODERNA THERAPEUTICS, INC.
Reel/Frame 045859/0718 →